3 results match your criteria: "5113 Rollins Research Center[Affiliation]"
J Pharmacol Exp Ther
April 2005
Department of Pharmacology, Emory University School of Medicine, 5113 Rollins Research Center, 1510 Clifton Rd., Atlanta, GA 30322, USA.
The alpha1D-adrenergic receptor (alpha1D-AR) is a G protein-coupled receptor (GPCR) that is poorly trafficked to the cell surface and largely nonfunctional when heterologously expressed by itself in a variety of cell types. We screened a library of approximately 30 other group I GPCRs in a quantitative luminometer assay for the ability to promote alpha1D-AR cell surface expression. Strikingly, these screens revealed only two receptors capable of inducing robust increases in the amount of alpha1D-AR at the cell surface: alpha1B-AR and beta2-AR.
View Article and Find Full Text PDFSemin Cell Dev Biol
June 2004
Department of Pharmacology, Rollins Research Center, Emory University School of Medicine, 5113 Rollins Research Center, 1510 Clifton Rd., Atlanta, GA 30322, USA.
The three subtypes of beta-adrenergic receptor (beta AR) all interact with G proteins as a central aspect of their signaling. The various beta AR subtypes also associate differentially with a variety of other cytoplasmic and transmembrane proteins. These beta AR-interacting proteins play distinct roles in the regulation of receptor signaling and trafficking.
View Article and Find Full Text PDFBiochem Biophys Res Commun
September 2002
Department of Pharmacology, 5113 Rollins Research Center, Emory University School of Medicine, 1510 Clifton Rd., Atlanta, GA 30322, USA.
The beta(1)-adrenergic receptor (beta(1)AR) has one predicted site of N-linked glycosylation on its extracellular amino-terminus, but the glycosylation and potential functional importance of this site have not yet been examined. We show here that the beta(1)AR is glycosylated in various cell types and that mutation of the single predicted site of N-linked glycosylation (N15A) results in the formation of receptors that are not N-glycosylated. The beta(1)AR N15A mutant exhibited significantly decreased basal surface expression relative to the wild-type receptor but had no detectable deficits in ligand binding or agonist-promoted internalization.
View Article and Find Full Text PDF